You have 9 free searches left this month | for more free features.

Progressive Brain Tumor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor

Not yet recruiting
  • Pediatric Brain Tumor
  • +2 more
  • Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
  • Implantation
  • San Francisco, California
    University of California, San Francisco
May 24, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

Recruiting
  • Brain Tumor
  • +2 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta (CHOA)
Jul 24, 2022

Recurrent Brain Metastases, Progressive Brain Metastases Trial in United States (Meclofenamate)

Active, not recruiting
  • Recurrent Brain Metastases
  • Progressive Brain Metastases
  • Miami, Florida
  • +6 more
May 4, 2022

Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)

Recruiting
  • Brain Tumor, Recurrent
  • +3 more
  • Houston, Texas
    Texas Children's Cancer Center
Aug 15, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

Terminated
  • Glioblastoma Multiforme
  • +3 more
  • Indianapolis, Indiana
    Riley Hospital for Children at IU Health
Jul 21, 2022

Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

Active, not recruiting
  • Supratentorial Neoplasms, Malignant
  • +6 more
  • G207
  • Birmingham, Alabama
  • +1 more
Jun 1, 2022

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor Trial in Cleveland (AutoLITT system)

Completed
  • Brain Tumor
  • +5 more
  • AutoLITT system
  • Cleveland, Ohio
  • +1 more
Aug 23, 2021

Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)

Recruiting
  • Recurrent GBM
  • SONALA-001 (ALA) and Exablate device
  • Phoenix, Arizona
  • +2 more
Jan 6, 2023

Solid Tumor, Glioblastoma, Glioblastoma Multiforme Trial in Salt Lake City (C5252)

Recruiting
  • Solid Tumor
  • +3 more
  • C5252
  • Salt Lake City, Utah
    University of Utah
Feb 17, 2022

Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Palo Alto, California
  • +9 more
Aug 2, 2022

CNS Embryonal Tumor, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered, Germ Cell Tumor Trial in Minneapolis, Portland

Active, not recruiting
  • Central Nervous System Embryonal Neoplasm
  • +9 more
  • Minneapolis, Minnesota
  • +1 more
Oct 25, 2021

Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

Not yet recruiting
  • Rhabdoid Tumor
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 11, 2023

Among Pediatric Brain Tumor and Blood Cancer Patients

Recruiting
  • Brain Tumor, Pediatric
  • Blood Cancer
  • Neurocognitive tools
  • Karachi, Sindh, Pakistan
    Nida Zahid
Jan 30, 2023

Primary Progressive Aphasia Trial in Saint Paul (Intermittent theta burst stimulation)

Enrolling by invitation
  • Primary Progressive Aphasia
  • Intermittent theta burst stimulation
  • Saint Paul, Minnesota
    HealthPartners Neuroscience Center
May 17, 2023

Aphasia, Primary Progressive Trial in Columbia (Propranolol, Magnetic Resonance Imaging (MRI), Placebo)

Not yet recruiting
  • Aphasia, Primary Progressive
  • Columbia, Missouri
    University of Missouri-Columbia
Sep 27, 2023

Seizures, Brain Tumor Trial (Levetiracetam, Placebo)

Not yet recruiting
  • Seizures
  • Brain Tumor
  • (no location specified)
Jun 1, 2023

Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • Metformin Hydrochloride 850 mg Oral Tablet
  • Placebo
  • Brugge, Belgium
  • +4 more
May 30, 2023

Primary Progressive Aphasia, Frontotemporal Dementia, Alzheimer Trial in Madrid (Transcranial Magnetic Stimulation (active),

Recruiting
  • Primary Progressive Aphasia
  • +2 more
  • Transcranial Magnetic Stimulation (active)
  • +2 more
  • Madrid, Spain
    Hospital Clínico San Carlos.
Apr 24, 2023

Brain and CNS Tumors Trial in San Francisco, New York, Cleveland (HSPPC-96, Standard Surgical Resection)

Completed
  • Brain and Central Nervous System Tumors
  • HSPPC-96
  • Standard Surgical Resection
  • San Francisco, California
  • +2 more
May 11, 2021

Tumor Rebiopsy in Children and Recurrent or Progressive Solid

Active, not recruiting
  • Tumor, Solid
  • Re-biopsy
  • Questionnaire
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 10, 2022

Preclinical Brain Tumor Models

Recruiting
  • Brain Metastases
  • Diffuse Gliomas
  • Fresh tumor sampling
  • Marseille, France
    Assistance publique hopitaux de marseille
Sep 13, 2023

Circulating and Tumor-infiltrating Immune Cells in Malignant

Recruiting
  • Brain Tumor, Primary
  • Brain Tumor - Metastatic
  • Circulating leukocytes immunophenotype
  • Tumor sampling
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Apr 14, 2023